Removal of cancer cells by circulating virus-specific cytotoxic t-cells using cancer cell targeted mhc class 1 compromising multi-function proteins
AssigneeRoche Glycart AG
InventorsChristian Klein, Hendrik Knoetgen, Martina Schmittnaegel, Pablo Umana
Life of this patent
Estimating the term…